Claudio Hegenberger, MD, MBA, MSc

Claudio Hegenberger, MD,MBA, MSc is VP of Clinical Affairs at Emerald Clinical Trial. Dr. Hegenberger brings 27 years of global experience in all pharma Medical Affairs areas (Clinical Development and Operations, CROs' supervision, PV, MI, Safety, and country/regional MDs supervision), most recently serving as VP of Medical Affairs at Pfizer. With an MD in Internal Medicine, he holds multiple advanced degrees and certifications—including from Georgetown University, Mount Sinai Hospital, and Harvard — and became an Associate Professor of Internal Medicine in 2 universities in Argentina. Dr. Hegenberger leads Emerald’s Scientific and Clinical Affairs team and also supports strategic business development initiatives. Currently based in Madrid, he is fluent in English, Spanish, and German, and has extensive experience across all therapeutic areas Internal Medicine (CV, Metabolic, CNS & Pain, Nephrology, OTC line), Inflammation and Immunology, Vaccines, Oncology, Rare Diseases, and Hospital line.